The Company now expects the FDA's marketing authorization decision to be reached after the first quarter of 2025. "Given the novelty of our product and the importance of breast cancer in public ...

"Given the novelty of our product and the importance of breast cancer in public health, the FDA has included many stakeholders in the discussion of the De Novo marketing clearance for ProSense ...

Akida first neuromorphic IP available on the market. Inspired by the biological function of neurons and engineered on a digital logic process, the Akida’s event-based spiking neural network ... The ...

Boston, Massachusetts--(Newsfile Corp. - March 8, 2025) - Expert Consumers has recognized Klaviyo as the top SMS marketing platform for 2025, citing its seamless integration with marketing ...